Lin BioScience, Inc. (TPEX:6696)
Taiwan · Delayed Price · Currency is TWD 169.00
+6.00 (3.68%)
Sep 17, 2026, 2:05 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 135.16 billion as of September 17, 2026. Its market cap has increased by 908.54% in one year.
Market Cap
135.16B
Enterprise Value
133.62B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
169.00
ChartMarket Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 135.16B, an increase of 4,534.95%. That is a compound annual growth rate of 62.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 135.16B | 311.55% |
| Dec 31, 2025 | 32.84B | 203.76% |
| Dec 31, 2024 | 10.81B | 20.85% |
| Dec 29, 2023 | 8.95B | -28.90% |
| Dec 30, 2022 | 12.58B | -1.94% |
| Dec 30, 2021 | 12.83B | 83.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 123.34B |
| Pell Bio-Med Technology | 73.12B |
| Sunmax Biotechnology | 21.79B |
| Oneness Biotech | 21.05B |
| Medigen Vaccine Biologics | 19.33B |
| CHO Pharma | 18.16B |
| TaiMed Biologics | 16.36B |
| Ever Supreme Bio Technology | 15.51B |